Advanced search
Publication Cover
Dermato-Endocrinology Volume 8, 2016 - Issue 1
Journal homepage
640
Views
4
CrossRef citations to date
0
Altmetric
Letter to the Editor

The disintegrin-metalloproteinases ADAM10 and ADAM17 are upregulated in cutaneous squamous cell carcinomas

S.-T. OhDepartment of Dermatology, The Saarland University Hospital, Homburg/Saar, Germany;Department of Dermatology, Daejeon St. Mary's Hospital, The Medical College of the Catholic University of Korea, Daejeon, South KoreaCorrespondence[email protected]
,
A. StarkDepartment of Dermatology, The Saarland University Hospital, Homburg/Saar, Germany
&
J. ReichrathDepartment of Dermatology, The Saarland University Hospital, Homburg/Saar, Germany
Article: e1228499 | Received 28 Mar 2016, Accepted 18 Aug 2016, Published online: 31 Aug 2016

References

  • Sahin U, Weskamp G, Kelly K, Zhou HM, Higashiyama S, Peschon J, Hartmann D, Saftig P, Blobel CP. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J Cell Biol 2004; 164:769-79; PMID:14993236; http://dx.doi.org/10.1083/jcb.200307137
  • Higashiyama S, Nanba D. ADAM-mediated ectodomain shedding of HB-EGF in receptor cross-talk. Biochim Biophys Acta 2005; 1751:110-7; PMID:16054021
  • Miyamoto S, Yagi H, Yotsumoto F, Kawarabayashi T, Mekada E. Heparin-binding epidermal growth factor-like growth factor as a novel targeting molecule for cancer therapy. Cancer Sci 2006; 97:341-7; PMID:16630129; http://dx.doi.org/10.1111/j.1349-7006.2006.00188.x
  • Kivisaari AK, Kallajoki M, Ala-aho R, McGrath JA, Bauer JW, Königová R, Medvecz M, Beckert W, Grénman R, Kähäri VM. Matrix metalloproteinase-7 activates heparin-binding epidermal growth factor-like growth factor in cutaneous squamous cell carcinoma. Br J Dermatol 2010; 163:726-35.
  • Saftig P, Reiss K. The “A Disintegrin And Metalloproteases” ADAM10 and ADAM17: novel drug targets with therapeutic potential? Eur J Cell Biol 2011; 90:527-35; PMID:21194787; http://dx.doi.org/10.1016/j.ejcb.2010.11.005
  • Mechtersheimer S, Gutwein P, Agmon-Levin N, Stoeck A, Oleszewski M, Riedle S, Postina R, Fahrenholz F, Fogel M, Lemmon V, et al. Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins. J Cell Biol 2001; 155:661-73; PMID:11706054; http://dx.doi.org/10.1083/jcb.200101099
  • Reiss K, Maretzky T, Ludwig A, Tousseyn T, de Strooper B, Hartmann D, Saftig P. ADAM10 cleavage of N-cadherin and regulation of cell-cell adhesion and beta-catenin nuclear signalling. EMBO J 2005; 24:742-52; PMID:15692570; http://dx.doi.org/10.1038/sj.emboj.7600548
  • Arima T, Enokida H, Kubo H, Kagara I, Matsuda R, Toki K, Nishimura H, Chiyomaru T, Tatarano S, Idesako T, et al. Nuclear translocation of ADAM-10 contributes to the pathogenesis and progression of human prostate cancer. Cancer Sci 2007; 98:1720-6; PMID:17727679; http://dx.doi.org/10.1111/j.1349-7006.2007.00601.x
  • McCulloch DR, Akl P, Samaratunga H, Herington AC, Odorico DM. Expression of the disintegrin metalloprotease, ADAM-10, in prostate cancer and its regulation by dihydrotestosterone, insulin-like growth factor I, and epidermal growth factor in the prostate cancer cell model LNCaP. Clin Cancer Res 2004; 10:314-23; PMID:14734484; http://dx.doi.org/10.1158/1078-0432.CCR-0846-3

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.